Trials / Terminated
TerminatedNCT02938078
Ocular Comfort and Inflammation in Lid Hygiene Therapy
Ocular Comfort and Markers of Inflammation in Subjects Undergoing Lid Hygiene Therapy
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Minnesota Eye Consultants, P.A. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary study objectives are: to evaluate (1) the change in ocular discomfort at 30 days and (2) the change in signs and symptoms of ocular surface disease in demodex-positive subjects beginning the use of Avenova.
Detailed description
This is a prospective study of subjects who have been diagnosed with bilateral demodex blepharitis. Qualified symptomatic eyes will be randomized and monitored for 30 days; one eye will undergo Avenova treatment twice daily and one eye will not undergo any study treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Avenova Lid Cleanser | Avenova lid cleanser is an FDA-cleared saline solution preserved with 0.01% pure hypochlorous acid. |
Timeline
- Start date
- 2016-10-01
- Primary completion
- 2018-08-24
- Completion
- 2018-08-24
- First posted
- 2016-10-19
- Last updated
- 2020-08-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02938078. Inclusion in this directory is not an endorsement.